The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_001354304.2:c.441+5G>A

CA16020788

987910 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: a88497a0-043d-48a7-8d68-1d6d90f282f4
Approved on: 2020-09-12
Published on: 2020-09-12

HGVS expressions

NM_001354304.2:c.441+5G>A
NC_000012.12:g.102877457C>T
CM000674.2:g.102877457C>T
NC_000012.11:g.103271235C>T
CM000674.1:g.103271235C>T
NC_000012.10:g.101795365C>T
NG_008690.1:g.45146G>A
NG_008690.2:g.85954G>A
ENST00000553106.6:c.441+5G>A
ENST00000307000.7:c.426+5G>A
ENST00000549111.5:n.537+5G>A
ENST00000550978.6:c.430G>A
ENST00000551988.5:n.530+5G>A
ENST00000553106.5:c.441+5G>A
NM_000277.1:c.441+5G>A
NM_000277.2:c.441+5G>A
NM_001354304.1:c.441+5G>A
NM_000277.3:c.441+5G>A
More

Uncertain Significance

Met criteria codes 3
PM2 PP4_Moderate PM3_Supporting
Not Met criteria codes 1
BP7

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.441+5G>A variant in PAH is absent from population databases (PM2). It has been observed in at least one classic PKU patient with BH4 deficiency excluded (PMID: 18321666; PP4_moderate). The patient is compound heterozygous with pathogenic variant R158Q (ClinVar 587; PM3_supporting). In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PM3_supporting, PP4_moderate.
Met criteria codes
PM2
c.441+5G>A is absent from population databases including gnomAD, ExAC, 1000 Genomes, and ESP.
PP4_Moderate
NL patient 3 of PMID: 18321666 has classic PKU with serum Phe levels of 2388uM. BH4 deficiency was excluded by urine analysis for putative abnormalities in biopterin metabolism.

PM3_Supporting
NL patient 3 of PMID: 18321666 is compound heterozygous for c.441+5G>A and R158Q (ClinVar 587, Pathogenic reviewed by VCEP). Confirmation of phase not reported.
Not Met criteria codes
BP7
HSF and MaxEntScan agree that there is no significant impact on splicing signals. However the nucleotide is highly conserved throughout vertebrates (PhyloP score 7.24).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.